|
|
|
|
LEADER |
03234nam a2200505Ia 4500 |
001 |
10.1111-clr.13147 |
008 |
220706s2018 CNT 000 0 und d |
020 |
|
|
|a 09057161 (ISSN)
|
245 |
1 |
0 |
|a Randomized controlled clinical study assessing two membranes for guided bone regeneration of peri-implant bone defects: 3-year results
|
260 |
|
0 |
|b Blackwell Munksgaard
|c 2018
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1111/clr.13147
|
520 |
3 |
|
|a Objectives: To assess two- and three-dimensional changes of the peri-implant tissues as well as clinical, biological, and radiological outcomes of implants having been treated with resorbable or nonresorbable membranes at 3 years. Materials and methods: Twenty-three patients were re-examined after having received a single-tooth implant in the esthetic zone in conjunction with guided bone regeneration (GBR) using either a resorbable (RES) or a titanium-reinforced nonresorbable membrane (N-RES) and demineralized bovine bone mineral. Volumetric and linear as well as clinical and radiographic measurements were performed at crown insertion (baseline), at 1 year (FU-1) and 3 years (FU-3). Statistics were performed by means of parametric and nonparametric tests. Results: Minor, but ongoing buccal volume loss was observed in both groups during the 3-year follow-up. A slightly higher volume loss was observed in group RES (−0.22 mm) compared to N-RES (−0.14 mm) at 1 year (FU-1), but aligned at 3 years (FU-3) RES (−0.30 mm) N-RES (−0.32 mm). All changes over time were statistically significantly different within (p <.05), but not between the groups (p >.05). Stable median interproximal bone levels after 3 years (FU-3); 0.26 mm (0.04; 0.36) (RES) and 0.14 mm (0.08; 0.20) (N-RES) and healthy tissues (BOP, PD) were obtained with both membranes. Conclusions: Both treatment modalities resulted in minor, but ongoing contour changes of the peri-implant tissues. Stable interproximal bone levels and healthy tissues can be obtained with membranes up to 3 years. © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
|
650 |
0 |
4 |
|a alveolar ridge augmentation
|
650 |
0 |
4 |
|a Alveolar Ridge Augmentation
|
650 |
0 |
4 |
|a bone prosthesis
|
650 |
0 |
4 |
|a Bone Substitutes
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a Dental Implantation, Endosseous
|
650 |
0 |
4 |
|a dental implants
|
650 |
0 |
4 |
|a Dental Implants, Single-Tooth
|
650 |
0 |
4 |
|a drug therapy
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a Female
|
650 |
0 |
4 |
|a Guided Tissue Regeneration, Periodontal
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a Male
|
650 |
0 |
4 |
|a membranes
|
650 |
0 |
4 |
|a middle aged
|
650 |
0 |
4 |
|a Middle Aged
|
650 |
0 |
4 |
|a periodontal guided tissue regeneration
|
650 |
0 |
4 |
|a procedures
|
650 |
0 |
4 |
|a randomized controlled trial
|
650 |
0 |
4 |
|a single tooth implant
|
650 |
0 |
4 |
|a tooth implantation
|
650 |
0 |
4 |
|a volume stability
|
650 |
0 |
4 |
|a volumetric analysis
|
700 |
1 |
|
|a Basler, T.
|e author
|
700 |
1 |
|
|a Hämmerle, C.H.F.
|e author
|
700 |
1 |
|
|a Jung, R.E.
|e author
|
700 |
1 |
|
|a Naenni, N.
|e author
|
700 |
1 |
|
|a Schneider, D.
|e author
|
700 |
1 |
|
|a Thoma, D.S.
|e author
|
773 |
|
|
|t Clinical Oral Implants Research
|